OCUGEN INC. - COMMON STOCK
1.9200
20-May-24 14:59:59
15 minutes delayed
Stocks
+0.0100
+0.52%
Today's range
1.8700 - 1.9700
ISIN
N/A
Source
NASDAQ
-
Ocugen to Present at Investing in Cures Summit
06 Mar 2024 06:30:09 By Nasdaq GlobeNewswire
-
Ocugen Clinical Showcase Webcast Now Available
28 Feb 2024 07:00:26 By Nasdaq GlobeNewswire
-
Ocugen Chairman and CEO to present at Abu Dhabi Family Office Summit
26 Feb 2024 07:30:13 By Nasdaq GlobeNewswire
-
22 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Ocugen to Present at 2024 BIO CEO & Investor Conference
21 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
14 Feb 2024 06:30:49 By Nasdaq GlobeNewswire
-
Ocugen to Present at Pharma Market Research Conference
31 Jan 2024 07:00:12 By Nasdaq GlobeNewswire
-
Ocugen, Inc. Announces Bob Smith Joins Business Advisory Board
16 Jan 2024 06:30:58 By Nasdaq GlobeNewswire
-
21 Dec 2023 05:30:09 By Nasdaq GlobeNewswire
-
19 Dec 2023 06:30:00 By Nasdaq GlobeNewswire
-
29 Nov 2023 06:30:12 By Nasdaq GlobeNewswire
-
10 Nov 2023 06:30:37 By Nasdaq GlobeNewswire
-
Ocugen Provides Business Update with Third Quarter 2023 Financial Results
09 Nov 2023 05:30:00 By Nasdaq GlobeNewswire
-
Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit
07 Nov 2023 06:45:14 By Nasdaq GlobeNewswire
-
02 Nov 2023 06:30:06 By Nasdaq GlobeNewswire
-
10 Oct 2023 05:30:48 By Nasdaq GlobeNewswire
-
Ocugen to Present at the 2023 Cell & Gene Meeting on the Mesa
04 Oct 2023 06:00:20 By Nasdaq GlobeNewswire
-
Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference
29 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference
27 Sep 2023 18:30:50 By Nasdaq GlobeNewswire